Search clinical trials for: CP and REACT

Total 272682 results

Aga Khan University

Completed

Convalescent Plasma Treatment in COVID-19 (COLLATE)

Covid19

Pakistan
AstraZeneca

Completed

Randomized Study Of CP-675,206 or Best Supportive Care Immediately After Platinum-Based Therapy For Non-Small Cell Lung Cancer (NSCLC)

Carcinoma, Non-small-cell Lung

United States, Canada, Korea, Republic of, United Kingdom, Czech Republic
Southern Medical University, China

Unknown

Tumor Classification and Its Application in Surgical Treatment of Craniopharyngioma

Craniopharyngioma

China
VA Office of Research and Development

Recruiting

A Balanced Reach Training Platform to Address Balance Disorders in Older and Neurologically Disabled Veterans (BRTP)

Older Men and Women With High Fall Risk

United States
Lehigh University
National Institute on Drug Abuse (NIDA); University of Kansas Medical Center

Recruiting

Telephone All Nations Breath of Life (tANBL)

Smoking Cessation

United States
Abiomed Inc.

Recruiting

Primary Unloading and Delayed Reperfusion in ST-Elevation Myocardial Infarction: The STEMI-DTU Trial (DTU-STEMI)

ST Elevation (STEMI) Myocardial Infarction of Anterior Wall

United States, Canada, Italy, Germany, Switzerland, United Kingdom, Netherlands
VA Office of Research and Development

Completed

Biomechanics of Wheelchair Transfers

Spinal Cord Injury

United States
VA Office of Research and Development
VA Maryland Health Care System

Recruiting

Assessment and Treatment for Chronic Pain in Veterans With Serious Mental Illness (CPSMI)

Psychotic Disorders | Schizophrenia | Chronic Pain | Bipolar Disorder | Affective Disorders, Psychotic

United States
Regen Lab SA

Unknown

Comparative Evaluation of A-CP HA Kit, Hyaluronic Acid and Placebo for the Treatment of Knee Osteoarthritis

Knee Osteoarthritis

United States
Arog Pharmaceuticals, Inc.

Completed

Study of Crenolanib in Recurrent/Refractory Glioblastoma With PDGFRA Gene Amplification

Recurrent/Refractory Glioblastoma

United States
VA Office of Research and Development
VA Connecticut Healthcare System; North Texas Veterans Healthcare System

Not yet recruiting

Assessing the Efficacy of an Acceptance-Based Digital Intervention for Veterans With Chronic Pain (VACT-CP)

Chronic Pain

United States
Wake Forest University Health Sciences
Agency for Healthcare Research and Quality (AHRQ)

Recruiting

CARE-CP (Testing a Cardiovascular Ambulatory Rapid Evaluation for Patients With Chest Pain) (CARE-CP)

Chest Pain

United States
Istanbul Medeniyet University

Unknown

Turkish Version of the Mini-BESTest: Transcultural Adaptation and Validation Study in Stroke Patients

Stroke | Balance; Distorted

Turkey
Arog Pharmaceuticals, Inc.

Terminated

Study of Crenolanib, a Selective and Potent Inhibitor of PDGFR, for the Treatment of Adult Gliomas

Glioma

United States
University Health Network, Toronto

Terminated

Safety Study of Radiation and CP-675,206 Infusion for Breast Cancer Patients

Metastatic Breast Cancer

Canada
Bezmialem Vakif University

Completed

Increased Femoral Anteversion and Physical Performance

Muscle Strength | Functional Capacity | Functional Performance | Flexibility | High Femoral Anteversion

Turkey
Johnson & Johnson Consumer and Personal Products...

Completed

Study of an Experimental Toothbrush for Treatment and Prevention of Gingivitis

Dental Devices, Home Care

United States
Medical University of Graz

Not yet recruiting

Impact of Hepatitis B Immunoglobulins in Patients With Chronic Hepatitis B on Hepatocellular Carcinoma - a Proof of Concept Study (HBIG)

Hepatocellular Carcinoma | HBV
Pfizer

Terminated

A 14-Month Study On The Effects Of CP-945,598 For The Prevention Of Weight Regain In Obese Patients

Obesity

United States, Australia, Denmark, Netherlands, South Africa
University of Wisconsin, Madison
Pfizer

Withdrawn

Study of CP-675,206 in Bacillus Calmette-Guerin (BCG)-Resistant Bladder Cancer

Bladder Cancer
Mahidol University

Not yet recruiting

Performance of Novel Simplified Score for Chronic Hepatitis B Treatment Eligibility in Thailand

Chronic Hepatitis B

Thailand
City of Hope Medical Center
National Cancer Institute (NCI)

Recruiting

Durvalumab and Tremelimumab After Radioembolization for the Treatment of Unresectable, Locally Advanced Liver Cancer

Unresectable Hepatocellular Carcinoma | Stage III Hepatocellular Carcinoma AJCC v8 | Stage IIIA Hepatocellular Carcinoma AJCC v8 | Stage IV Hepatocellular Carcinoma AJCC v8 | Stage IVA Hepatocellular Carcinoma AJCC v8 | Stage IVB Hepatocellular Carcinoma AJCC v8 | BCLC Stage B Hepatocellular Carcinoma and other conditions

United States
M.D. Anderson Cancer Center

Recruiting

Durvalumab and Tremelimumab in Treating Participants With Recurrent or Refractory Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

Recurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Platinum-Resistant Fallopian Tube Carcinoma | Platinum-Resistant Primary Peritoneal Carcinoma | Platinum-Resistant Ovarian Carcinoma | Refractory Ovarian Carcinoma | Refractory Fallopian Tube... and other conditions

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Completed

Durvalumab and Tremelimumab Before Surgery in Treating Patients With Hormone Receptor Positive, HER2 Negative Stage II-III Breast Cancer

Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage IIA Breast Cancer AJCC v8 | Anatomic Stage IIB Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IIIA Breast Cancer AJCC v8 | Anatomic Stage IIIB Breast Cancer AJCC v8 | Anatomic Stage IIIC Breast Cancer AJCC... and other conditions

United States
F. Stephen Hodi, MD
MedImmune LLC

Completed

Phase I Clinical Trial of Tremelimumab Plus MEDI3617 in Patients With Unresectable Stage III or Stage IV Melanoma

Metastatic Melanoma

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Completed

Durvalumab and Tremelimumab in Treating Chemotherapy Naive Patients With Metastatic Castration-Resistant Prostate Cancer

Castration-Resistant Prostate Carcinoma | Prostate Adenocarcinoma | Stage IV Prostate Cancer AJCC v8 | Metastatic Malignant Neoplasm in the Bone | Stage IVA Prostate Cancer AJCC v8 | Stage IVB Prostate Cancer AJCC v8

United States
Novartis
Procter and Gamble

Completed

Using Behavioral Therapy in Combination With Darifenacin for Symptoms of Overactive Bladder

Urinary Incontinence

United States
AstraZeneca

Completed

Study of Ticilimumab in Patients With Metastatic Colorectal Cancer Whose Disease Had Progressed After Treatment

Colorectal Neoplasms

United States, Canada
Biotest

Active, not recruiting

Prevention of Maternal-fetal Cytomegalovirus Transmission After Primary Maternal Infection, GW ≤ 14 (PreCyssion) (PreCyssion)

Congenital Cytomegalovirus Infection

Germany
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Active, not recruiting

Durvalumab and Tremelimumab in Treating Patients With Muscle-Invasive, High-Risk Urothelial Cancer That Cannot Be Treated With Cisplatin-Based Therapy Before Surgery

Hydronephrosis | Infiltrating Bladder Urothelial Carcinoma, Plasmacytoid Variant | Stage III Bladder Urothelial Carcinoma AJCC v6 and v7 | Stage III Renal Pelvis Cancer AJCC v7 | Stage III Ureter Cancer AJCC v7 | Stage III Urethral Cancer AJCC v7 | Stage IV Renal Pelvis Cancer AJCC v7 | Stage IV... and other conditions

United States
SWOG Cancer Research Network
National Cancer Institute (NCI)

Completed

Durvalumab and Tremelimumab in Treating Patients With Recurrent Stage IV Lung Cancer

Recurrent Squamous Cell Lung Carcinoma | Stage IV Squamous Cell Lung Carcinoma AJCC v7

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Completed

Durvalumab With or Without Tremelimumab in Treating Participants With Stage II-IVA Oropharyngeal Squamous Cell Cancer

Stage IVA Oropharyngeal Squamous Cell Carcinoma AJCC v7 | Stage III Oropharyngeal Squamous Cell Carcinoma AJCC v7 | Stage II Oropharyngeal Squamous Cell Carcinoma AJCC v6 and v7

United States
AstraZeneca

Completed

A Rollover Study for Patients Who Received Tremelimumab in Other Protocols, to Allow the Patients Access to Tremelimumab Until This Agent Becomes Commercially Available or Development is Discontinued.

Melanoma | Neoplasms | Renal Cell Carcinoma | Prostatic Neoplasms | Colorectal Neoplasms | Patients Who Have/Have Had Melanoma and Other Tumors

United States, United Kingdom
Grupo Espanol de Tumores Neuroendocrinos

Completed

Durvalumab (MEDI4736) Plus Tremelimumab for Advanced Neuroendocrine Neoplasms of Gastroenteropancreatic or Lung Origin (DUNE)

Neuroendocrine Tumors | Neuroendocrine Neoplasm of Lung

Spain
China Medical University Hospital

Completed

The Effect of Probiotics on Type 1 Diabetes Mellitus in Children

Type 1 Diabetes Mellitus

Taiwan
Arog Pharmaceuticals, Inc.

Completed

Study of Crenolanib for the Treatment of Patients With Advanced GIST With the D842-related Mutations and Deletions in the PDGFRA Gene

D842-related Mutant GIST

United States
GERCOR - Multidisciplinary Oncology Cooperative...
AstraZeneca

Active, not recruiting

Durvalumab + Tremelimumab ± Paclitaxel in Advanced BTC After Platinum Chemotherapy. (IMMUNO-BIL)

Advanced Biliary Tract Carcinoma

France
Columbia University

Withdrawn

Durvalumab and Tremelimumab for Adjuvant Therapy of Resected NSCLC

Non-small Cell Lung Cancer
Pfizer

Terminated

Long-Term Safety Study Of Inhaled Insulin (CP-464,005, Inhaler) In Japanese Patients With Type1 or Type2 Diabetes

Diabetes Mellitus, Type 2 | Diabetes Mellitus, Type 1

Japan
City of Hope Medical Center
National Cancer Institute (NCI)

Completed

Durvalumab and Tremelimumab in Treating Patients With Microsatellite Stable Metastatic Colorectal Cancer to the Liver

MLH1 Gene Mutation | Stage IV Colorectal Cancer | Stage IVA Colorectal Cancer | Stage IVB Colorectal Cancer | Metastatic Carcinoma in the Liver | MSH6 Gene Mutation | PMS2 Gene Mutation

United States
Michigan State University
Henry Ford Health System; Butler Hospital; Pacific Institute for Research and...

Recruiting

The ROSE Scale-up Study: Informing a Decision About ROSE as Universal PPD Prevention (ROSES-II)

Postpartum Depression

United States
Pfizer

Completed

Study To Examine Effect Of CP-866,087 On Consumption And Craving Of Alcohol In Alcohol Dependent Subjects.

Alcoholism

United States
Mary Feng, MD
AstraZeneca

Recruiting

Hypofractionated Radiotherapy Followed by Durvalumab With or Without Tremelimumab for Liver Cancer After Progression on PD-1 Inhibition

Advanced Hepatocellular Carcinoma | Stage III Hepatocellular Carcinoma AJCC v8 | Stage IIIA Hepatocellular Carcinoma AJCC v8 | Stage IV Hepatocellular Carcinoma AJCC v8 | Stage IVA Hepatocellular Carcinoma AJCC v8 | Stage IVB Hepatocellular Carcinoma AJCC v8 | Stage IIIB Hepatocellular Carcinoma...

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Active, not recruiting

Durvalumab, Tremelimumab, and Selumetinib in Treating Participants With Recurrent or Stage IV Non-small Cell Lung Cancer

Stage IVA Lung Cancer AJCC v8 | Stage IVB Lung Cancer AJCC v8 | Stage IV Lung Cancer AJCC v8 | Recurrent Lung Non-Small Cell Carcinoma

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Completed

Tremelimumab and Durvalumab in Treating Patients With Colorectal Cancer With Liver Metastases That Can Be Removed by Surgery

Stage IV Colorectal Cancer AJCC v7 | Stage IVA Colorectal Cancer AJCC v7 | Stage IVB Colorectal Cancer AJCC v7 | Metastatic Carcinoma in the Liver | Resectable Mass

United States
VA Office of Research and Development

Completed

Mindful Action for Pain (MAP)

Chronic Pain

United States
Dana-Farber Cancer Institute
AstraZeneca

Suspended

A Phase 2 Study of Durvalumab in Combination With Tremelimumab in Malignant Pleural Mesothelioma

Mesothelioma

United States
Virginia Commonwealth University

Recruiting

Decreasing Long-term Opioid Use in Cancer Survivors

Pain | Chronic Pain | Cancer Pain | Survivorship

United States
Washington Institute for Coagulation
Genentech, Inc.

Completed

Handheld Ultrasound (HHUS) for Home Use in Hemophilia (HHUS)

Hemophilia A | Joint Bleed

United States
Columbia University
Patient-Centered Outcomes Research Institute; NYU Langone Health; Alzheimer's... and other collaborators

Completed

Northern-Manhattan Hispanic Caregiver Intervention Effectiveness Study (NHiCE)

Depressive Symptoms | Burden

United States

Search clinical trials for: CP and REACT

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Indonesia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations